DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Wiviott SD, Braunwald E, Angiolillo DJ et al.
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction.
Circulation 2008;
118: 1626-1636
We do not assume any responsibility for the contents of the web pages of other providers.